E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis

[1]  Alexander R. Pico,et al.  WikiPathways: connecting communities , 2020, Nucleic Acids Res..

[2]  K. Rogers,et al.  A toolbox for imaging RIPK1, RIPK3, and MLKL in mouse and human cells , 2020, Cell Death & Differentiation.

[3]  Guo Zhang,et al.  Association between PTGER4 polymorphisms and inflammatory bowel disease risk in Caucasian , 2020, Medicine.

[4]  C. Becker,et al.  Cell death in the gut epithelium and implications for chronic inflammation , 2020, Nature reviews: Gastroenterology & hepatology.

[5]  R. Paulssen,et al.  Transcriptional Signatures That Define Ulcerative Colitis in Remission , 2020, Inflammatory bowel diseases.

[6]  O. Nielsen,et al.  SMAC mimetics and RIPK inhibitors as therapeutics for chronic inflammatory diseases , 2020, Science Signaling.

[7]  H. Seno,et al.  Epithelial EP4 plays an essential role in maintaining homeostasis in colon , 2019, Scientific Reports.

[8]  G. Kollias,et al.  Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation. , 2019, Gastroenterology.

[9]  Gui-Qiu Hu,et al.  MLKL deficiency inhibits DSS‐induced colitis independent of intestinal microbiota , 2019, Molecular immunology.

[10]  M. Neurath,et al.  Hobit- and Blimp-1-driven CD4+ tissue-resident memory T cells control chronic intestinal inflammation , 2019, Nature Immunology.

[11]  S. Shen-Orr,et al.  Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response , 2019, Nature Communications.

[12]  H. Clevers,et al.  Intestinal Inflammation and Dysregulated Immunity in Patients With Inherited Caspase-8 Deficiency. , 2019, Gastroenterology.

[13]  T. Hirokawa,et al.  Ligand binding to human prostaglandin E receptor EP4 at the lipid-bilayer interface , 2018, Nature Chemical Biology.

[14]  J. Bertin,et al.  Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell death , 2018, Science.

[15]  H. Wajant,et al.  Soluble TNF-like weak inducer of apoptosis (TWEAK) enhances poly(I:C)-induced RIPK1-mediated necroptosis , 2018, Cell Death & Disease.

[16]  D. Aronoff,et al.  COX-2–PGE2 Signaling Impairs Intestinal Epithelial Regeneration and Associates with TNF Inhibitor Responsiveness in Ulcerative Colitis , 2018, EBioMedicine.

[17]  Junying Yuan,et al.  TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging , 2018, Cell.

[18]  M. Neurath,et al.  Resolution of chronic inflammatory disease: universal and tissue-specific concepts , 2018, Nature Communications.

[19]  B. Levy,et al.  PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo , 2017, Science Advances.

[20]  Junying Yuan,et al.  Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis , 2017, Nature Communications.

[21]  Zhigao Wang,et al.  MLKL forms disulfide bond-dependent amyloid-like polymers to induce necroptosis , 2017, Proceedings of the National Academy of Sciences.

[22]  G. Rogler.  Resolution of inflammation in inflammatory bowel disease. , 2017, The lancet. Gastroenterology & hepatology.

[23]  I. Brodsky,et al.  NAIP‐NLRC4 Inflammasomes Coordinate Intestinal Epithelial Cell Expulsion with Eicosanoid and IL‐18 Release via Activation of Caspase‐1 and ‐8 , 2017, Immunity.

[24]  I. Mlinarič-Raščan,et al.  Structural features of subtype-selective EP receptor modulators. , 2017, Drug discovery today.

[25]  P. Vandenabeele,et al.  The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis. , 2016, The Journal of clinical investigation.

[26]  Haifeng Yin,et al.  TAK1 regulates caspase 8 activation and necroptotic signaling via multiple cell death checkpoints , 2016, Cell Death and Disease.

[27]  M. Bertrand,et al.  More to Life than NF-κB in TNFR1 Signaling. , 2016, Trends in immunology.

[28]  J. Ninomiya-Tsuji,et al.  TAK1 regulates Paneth cell integrity partly through blocking necroptosis , 2016, Cell Death and Disease.

[29]  T. Taniguchi,et al.  PGE2 induced in and released by dying cells functions as an inhibitory DAMP , 2016, Proceedings of the National Academy of Sciences.

[30]  R. Maizels,et al.  Prostaglandin E2 constrains systemic inflammation through an innate lymphoid cell–IL-22 axis , 2016, Science.

[31]  Ryan Miller,et al.  WikiPathways: capturing the full diversity of pathway knowledge , 2015, Nucleic Acids Res..

[32]  Isabelle Cleynen,et al.  Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.

[33]  Albert J R Heck,et al.  PhosphoPath: Visualization of Phosphosite-centric Dynamics in Temporal Molecular Networks. , 2015, Journal of proteome research.

[34]  A. Rosenwald,et al.  Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD. , 2015, Blood.

[35]  Takuji Tanaka,et al.  KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration. , 2015, European journal of pharmacology.

[36]  Junying Yuan.  Faculty Opinions recommendation of Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. , 2015 .

[37]  J. Bertin,et al.  Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death , 2015, Cell Death and Disease.

[38]  Timothy L. Tickle,et al.  Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. , 2014, The Journal of clinical investigation.

[39]  Jie Huang,et al.  Notch3 pathway alterations in ovarian cancer. , 2014, Cancer research.

[40]  M. Bertrand,et al.  MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. , 2014, Cell reports.

[41]  Jiahuai Han,et al.  Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death , 2013, Cell Research.

[42]  C. Falcone,et al.  Role of the advanced glycation end products receptor in Crohn's disease inflammation. , 2013, World journal of gastroenterology.

[43]  R. Duerr,et al.  PTGER4 Expression-Modulating Polymorphisms in the 5p13.1 Region Predispose to Crohn's Disease and Affect NF-κB and XBP1 Binding Sites , 2012, PloS one.

[44]  Akhilesh Pandey,et al.  A Bioinformatics Resource for TWEAK-Fn14 Signaling Pathway , 2012, Journal of signal transduction.

[45]  R. Young,et al.  Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis. , 2012, Bioorganic & medicinal chemistry.

[46]  Xiaodong Wang,et al.  Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase , 2012, Cell.

[47]  S. Pervaiz,et al.  Biphasic activity of CD137 ligand‐stimulated monocytes on T cell apoptosis and proliferation , 2011, Journal of leukocyte biology.

[48]  C. Gullo,et al.  Inhibition of Proliferation and Induction of Apoptosis in Multiple Myeloma Cell Lines by CD137 Ligand Signaling , 2010, PloS one.

[49]  S. Narumiya,et al.  Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: a randomized phase II, placebo-controlled trial. , 2010, Inflammatory bowel diseases.

[50]  G Van Assche,et al.  Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis , 2009, Gut.

[51]  Tao Wang,et al.  Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α , 2009, Cell.

[52]  H. Clevers,et al.  Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche , 2009, Nature.

[53]  I. Petersen,et al.  Prevalence of infectious pathogens in Crohn's disease. , 2009, Pathology, research and practice.

[54]  Jack Satsangi,et al.  Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis , 2008, Gut.

[55]  R. Faccio,et al.  RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. , 2008, The Journal of clinical investigation.

[56]  Simon Heath,et al.  Novel Crohn Disease Locus Identified by Genome-Wide Association Maps to a Gene Desert on 5p13.1 and Modulates Expression of PTGER4 , 2007, PLoS genetics.

[57]  Mike Tyers,et al.  BioGRID: a general repository for interaction datasets , 2005, Nucleic Acids Res..

[58]  D. Graves,et al.  Advanced Glycation End Products Enhance Expression of Pro-apoptotic Genes and Stimulate Fibroblast Apoptosis through Cytoplasmic and Mitochondrial Pathways* , 2005, Journal of Biological Chemistry.

[59]  T. Mizoguchi,et al.  Prostaglandin E2 Enhances Osteoclastic Differentiation of Precursor Cells through Protein Kinase A-dependent Phosphorylation of TAK1* , 2005, Journal of Biological Chemistry.

[60]  R. Young.  Discovery and Synthesis of a Potent, Selective and Orally Bioavailable EP4 Receptor Agonist , 2004 .

[61]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[62]  ハン，ヨンシン,et al.  Ep4 receptor agonist, compositions and methods thereof , 2003 .

[63]  R. Young,et al.  Discovery of a potent and selective agonist of the prostaglandin EP4 receptor. , 2003, Bioorganic & medicinal chemistry letters.

[64]  S. Narumiya,et al.  The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. , 2002, The Journal of clinical investigation.

[65]  Sumio Watanabe,et al.  Systemic and local evidence of increased Fas-mediated apoptosis in ulcerative colitis , 2002, International Journal of Colorectal Disease.

[66]  J. Morrow,et al.  Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. , 1998, Cancer research.

[67]  T. Koji,et al.  APOPTOSIS OF CRYPT EPITHELIAL CELLS IN ULCERATIVE COLITIS , 1996, The Journal of pathology.